PharmaCyte Biotech Inc (PMCB)

[videoguy]

I would expect PGs next PR to be how OraPhyte testing has been completed and that the product is viable. Why would that product, assuming the testing is positive and it gets fed approval be a success when the others are a failure. Many products are just sitting there, someone mentioned bringing the ibar back. Martin determined it wasn't viable. Maybe OraPhyte has less competition, it still needs to be better executed than what we're used to. Same goes for Citroxin. The products will be successful with new management, if it isn't fishy.